Abstract:Novel coronavirus infection is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and was named COVID-19 by the World Health Organization on January 7, 2020. In early December 2019, a number of pneumonia cases of unknown origin emerged in Wuhan, Hubei province, China. (1)(2) The disease then spread rapidly throughout China and has now become a global pandemic. As of March 23, 2020, more than 340,000 cases have been reported in more than 150 countries. Because the disease is primarily an airborne respiratory infection and is documented to have a strong human-to-human transmission, the pediatric and neonatal populations are vulnerable to this disease. However, the incidence and clinical presentations of pediatric COVID-19 infections are varied and differ from those found in adult patients. The atypical clinical presentations and 2 potential modes of transmission in neonates (ie, maternal-fetal or maternal-neonatal) have led to diagnostic and management challenges. In this perspective, we would like to share some published information from Chinese pediatric and neonatal societies about their approach to handling the 2019-2020 COVID-19 outbreak in China.Since the COVID-19 outbreak in December 2019, more than 81,000 confirmed cases have been reported in China (as of March 23, 2020). Most of these cases occurred between late January and early February 2020. The diagnosis of COVID-19 is based on the epidemiologic history of contact with an infected person, typical clinical features such as fever and respiratory distress, and a positive real-time polymerase chain reaction to the SARS-CoV-2 RNA test. The nucleic test is considered the gold standard for confirmation.As of February 8, 2020, 731 confirmed pediatric cases were reported in China, mainly from Wuhan city. (3) Relative to the total number of cases (n=34,664) reported in China, on February 8, 2020, the pediatric COVID-19 population accounted for 2.1% of all confirmed cases. In a more recent summary reporting 44,672 confirmed cases from the Chinese Center for Disease Control and Prevention, the percentage of pediatric infected patients was 1% of the total infected cases in children younger than 10 years (n=416) and 1% of the total infected cases in children between 10 and 19 years of age (n=549). (4) However, the incidence reported in a different city in China varied. Bi et al reported that in the city of Shenzhen, pediatric patients up to 19 years of age accounted for 8.2% of all cases. (5) Based on a recent census in Shenzhen, the percentage of the population that is below 19 years of age is 17%, suggesting that the affected number of pediatric cases of 8.2% should not be considered very low. (5) However, we do know that the severity of symptoms in pediatric patients with COVID-19 has been generally mild. Dong et al reported 731 confirmed pediatric cases and found that 94 patients (12.9%) were asymptomatic, 315 (43%) had mild symptoms, 300 (41%) had moderate symptoms, and 18 (2.5%) had severe symptoms. Only 3 (0.2%) of 731 pediatric patients were critically ill. (3)Thus far, only a limited number of confirmed neonatal cases have been reported in China. The possibility of maternal-to-fetal vertical transmission is a major concern among neonatal and perinatal societies. Direct evidence for vertical transmission of SARS-CoV-2 is lacking. Chen et al retrospectively reviewed the clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in 9 pregnant women in Wuhan city. (6) In this group, maternal clinical records, chest computed tomography (CT) scans, and laboratory-confirmed COVID-19 pneumonia (ie, using throat swab samples) were all consistent with the SARS-CoV-2 infection. All 9 patients had cesarean deliveries in their third trimester (between 36 0/7 and 39 4/7 weeks’ gestation). Nine live births were recorded. None of the newborns had perinatal depression. Amniotic fluid, cord blood, neonatal nasopharyngeal or throat swab, and breast milk samples for SARS-CoV-2 RNA from 6 mother-neonate dyads were tested, and all samples tested negative for the virus. (6) These results are similar to those found in the SARS-CoV-1 infection that occurred 17 years ago. (7) The interpretation of the findings from this recent small group of cases suggests that there is currently no evidence for intrauterine infection caused by vertical transmission in women who develop COVID-19 pneumonia in late pregnancy. Nonetheless, with the small sample size observed, the possibility of vertical transmission cannot be ruled out completely. In a report by Zhu et al, 10 pregnant women who tested positive for COVID-19 and delivered neonates (gestational age in weeks: 31, 31, 33 6/7, 34 2/7, 34 5/7, 34 6/7, 37 [large for gestational age], 38 4/7 [small for gestational age], 39, and 39 [large for gestational age]) were all negative for the SARS-CoV-2 RNA test. (8) Not surprisingly, it is difficult to distinguish potential COVID-19 symptoms from the common symptoms of mild respiratory distress syndrome, transient tachypnea of the newborn, and sepsis. In 1 particular neonate in this cohort (38 4/7 weeks, 2,450 g, small for gestational age), the chest CT scan showed a ground glass opacity pattern, which is the typical CT finding in adult patients with COVID-19. This neonate had mild respiratory distress but did not require mechanical ventilation, and the possibility of an infection with SARS-CoV-2 could not be ruled out. As such, the National Health Commission of China recently proposed strengthening family counseling, screening, and follow-up of infants born to COVID-19–positive women. There is still uncertainty about whether the duration of maternal viral infection and the birth gestational age affects the rate of positive test results in the neonate.The number of confirmed neonatal cases is limited. So far, 6 cases have been reported in China. (9)(10) One report of 5 cases was published in a Chinese journal and another case was reported by the local news media. Of these 6 patients, 1 presented with symptoms at 30 hours of age and tested positive for SARS-CoV-2 RNA at 36 hours after birth. However, whether this case represented a vertical transmission from the mother remains to be confirmed. (10) All 6 reported cases presented with nonspecific clinical symptoms or signs that did not require intubation and were discharged after complete recovery (Table).During the COVID-19 outbreak and mass quarantine implementation in late January and February 2020, most elective surgical procedures were postponed. Nonemergent hospital visits were decreased and the general medical ward capacity was reduced to at least 50%. This allowed hospitals to mobilize the space and manpower to concentrate on patients with COVID-19. Patients with COVID-19 were treated in special hospitals, designated as level III, which contain “negative pressure” wards (typically in isolated buildings) reserved for severe infectious disease admissions. When possible, infected or suspected neonates were admitted to this ward and the NICU team would be responsible for the infant’s care; these neonates were also placed in incubators to reduce the potential of airborne transmission between patients and health care personnel.For the COVID-19 response, perinatal and neonatal hospital providers relied on recent published consensus guidelines that were developed and published by Chinese neonatal and perinatal societies and lessons that were learned during the experience of the 2003 SARS-CoV outbreak. (11) The neonatal guideline focuses on perinatal infection prevention, high-risk neonatal transport, staff allocation and training, special equipment for transport, and intensive care preparation. The recommendations stress the importance of prevention and control of hospital infections. Family-integrated care and parental visits, including breastfeeding visits, are suspended during the neonate’s hospitalization. In addition to the standardized personal protective clothing and gloves, some specialized equipment or devices, such as ventilator exhaled port viral filters, suction catheters with a sealed sheath, and disposable ventilator tubing systems, are used in the specialized ward or during transport by ambulance. Staff are trained in infectious disease control, prevention, and the use and sequence of protective clothing, and practiced by all staff taking care of patients with COVID-19. The handling and disposal of dirty diapers is extremely important. It was recently reported that children with COVID-19 have prolonged fecal viral shedding for several weeks after clinical recovery. (12) It is still not known whether this viral shedding can lead to transmission of disease. Proper handling of diapers with stool or other secretions (especially respiratory) is potentially an important measure for decreasing the possibility of disease spread both within the unit and after discharge. It is currently unknown whether a bath would alter the risk of potential transmission.This management approach for neonates born to women with confirmed or suspected COVID-19 was based on Chinese consensus and was established using the current literature on this disease, government recommendations, and the experience from the SARS-CoV epidemic of 2003. (11) Although it is largely not evidence-based, these recommendations are widely practiced now in China for the care of neonates at risk of contracting COVID-19. The consensus flowsheet on neonatal COVID-19 management is summarized in the Figure. (13)During rigorous quarantine in early February 2020, the National Health Commission of China recommended postponing the routine follow-up hospital visits of newborns. As a result, neonatal health surveillance became challenging, especially for infants at risk for indirect hyperbilirubinemia. The following is an example of how we follow neonates for jaundice during the 2020 epidemic.To avoid frequent outpatient visits and reduce unnecessary readmissions during the COVID-19 epidemic, we launched a novel online follow-up program in February and March of 2020. (14) Before discharge, every parent is informed of the potential harm of indirect hyperbilirubinemia, the importance of bilirubin monitoring, the availability of online resources, and methods for assessing a newborn infant’s condition. In addition, families are provided with detailed information about COVID-19 and prevention strategies. We use a smartphone application (App) (Biliscan, available in Asia, Europe, and Africa) to monitor the transcutaneous bilirubin (TCB) levels of discharged patients. (15)(16) Prior to discharge, parents download and install the App on their smartphone and practice using the software under the direction of medical staff. The parents receive a color calibration card for use at home. To use this card, parents place the hollow square area of the card on the infant’s skin over the sternum. Parents then take a photograph of the card using the smartphone camera. The image data are then transmitted to the cloud for analysis, and the results of the TCB level are provided in seconds.Before the online follow-up meeting with the pediatric provider, parents are asked to check the TCB level by smartphone as described before, and also complete a questionnaire about their infant’s general clinical condition. The timing of this meeting is based on the infant’s birth gestational age, days after birth, and the TCB level on the discharge day. The physician then provides advice to the parents and determines the next online visit based on the newborn’s clinical scenario and the TCB level. If the App for TCB measurement is not available, parents can assess the degree of jaundice by observation in natural light. If the TCB level is higher than the 95th percentile in the first week after birth, more than 15 mg/dL (256.5 μmol/L) after 7 days of age, or the increment of bilirubin level is above 5 mg/dL (85.5 μmol/L) within 24 hours, the child is seen in an outpatient clinic. For infants with significant hyperbilirubinemia, we recommend hospitalization rather than outpatient daytime phototherapy, because the outpatient environment increases the risk for SARS-CoV-2 infection.This program has been used for 1 month in a level 3 maternal hospital. To validate the program, neonates who were diagnosed with ABO hemolytic disease and treated at the Women’s Hospital of Zhejiang University from January 20, 2020, to February 29, 2020, were followed using the home bilirubin App on the smart phone or TCB monitor (46 cases). These strategies were compared with routine outpatient follow-up during a similar period of 2018 (56 cases). No significant difference was noted between the 2 groups in the rates of readmission (8% vs 7%) and severe indirect hyperbilirubinemia after adjusting for gestational age, birthweight, delivery mode, gender peak bilirubin levels at first admission, and discharge (unpublished data). The authors concluded that the home-based strategy of follow-up is feasible and effective for neonates with ABO hemolysis after discharge during a period of mass quarantine.The current COVID-19 pandemic has become the most serious public health problem in the world. Children and newborns are not entirely exempt from the epidemic. Although most evidence-based prevention and control data are not fully available, the newly developed prevention and control consensus strategies for newborn COVID-19 are of great significance. We believe that this approach will protect newborns, their families, and health care professionals. Some of the steps of this consensus approach are currently being validated for use in clinical practice.

Abstract:Since December, 2019, a pneumonia of unknown cause, which has clinical manifestations similar to severe acute respiratory syndrome,1Zhu N Zhang D Wang W et al.A novel coronavirus from patients with pneumonia in China, 2019.N Engl J Med. 2020; (published online Jan 24.)DOI:10.1056/NEJMoa2001017Crossref PubMed Scopus (18604) Google Scholar, 2European Centre for Disease Prevention and ControlUpdate: cluster of pneumonia cases caused by a novel coronavirus, Wuhan, China.https://www.ecde.europa.eu/en/news-events/update-cluster-pneumonia-cases-associated-novel-coronavirus-wuhan-china-2019Date: 2019Date accessed: January 14, 2020Google Scholar originated in Wuhan, China, and has rapidly spread across China and to at least 23 countries. By Feb 5, 2020, the number of laboratory-confirmed cases had exceeded 20 000, with more than 400 deaths. About 100 children were affected, with the youngest being 30 h after birth. A novel virus named 2019 novel coronavirus (2019-nCoV) was considered to be the causative agent of this pneumonia. Neonates are thought to be susceptible to the virus because their immune system is not well developed, which is of great concern to neonatal medical service providers. Paediatricians and neonatologists belonging to the National Clinical Research Center for Child Health and Disorders and Pediatric Committee of Medical Association of Chinese People's Liberation Army have contributed to the control efforts in China. We aim to elicit a contingency plan for the 2019-nCoV outbreak in neonatal intensive care units (NICUs), mainly focused on diagnostic and discharge criteria, treatment, prevention, and control strategies. Most adults or children with 2019-nCoV infection presented with mild flu-like symptoms, although patients with severe illness could rapidly develop acute respiratory distress syndrome, respiratory failure, and multiple organ failure, and deaths have been reported in some cases.3Li AM Ng PC Severe acute respiratory syndrome (SARS) in neonates and children.Arch Dis Child Fetal Neonatal Ed. 2005; 90: F461-F465Crossref PubMed Scopus (88) Google Scholar Most patients with pneumonia had abnormal chest radiography findings, such as bilateral ground-glass opacity, multiple lobular, and subsegmental areas of consolidation;4Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; (published online Jan 24.)https://doi.org/10.1016/S0140-6736(20)30183-5Summary Full Text Full Text PDF Scopus (32891) Google Scholar those with acute respiratory distress syndrome could show bilateral complete opacification of the lungs on CT scans.1Zhu N Zhang D Wang W et al.A novel coronavirus from patients with pneumonia in China, 2019.N Engl J Med. 2020; (published online Jan 24.)DOI:10.1056/NEJMoa2001017Crossref PubMed Scopus (18604) Google Scholar Routine blood work was mostly unremarkable.4Huang C Wang Y Li X et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet. 2020; (published online Jan 24.)https://doi.org/10.1016/S0140-6736(20)30183-5Summary Full Text Full Text PDF Scopus (32891) Google Scholar The nucleic acid test from respiratory tract samples or serum is effective in detecting the virus, and results are usually available within 4–6 h.5WHOLaboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. World Health Organization, Geneva2019https://www.who.int/docs/default-source/coronaviruse/20200114-interim-laboratory-guidance-version.pdf?sfvrsn=6967c39b_4&download=trueDate accessed: January 17, 2020Google Scholar Neonates might get 2019-nCoV infection through close contact with virus-infected patients or virus carriers. In the case of neonatal infection, the disease might have insidious onset and be non-specific.6Gagneur A Vallet S Talbot PJ et al.Outbreaks of human coronavirus in a pediatric and neonatal intensive care unit.Eur J Pediatr. 2008; 167: 1427-1434Crossref PubMed Scopus (39) Google Scholar The diagnosis of 2019-nCoV neonatal infection should meet all the following requirements: (1) showing at least one of the clinical symptoms, including temperature instability, hypoactivity or poor feeding, or tachypnoea; (2) showing abnormal findings on chest radiograph, including unilateral or bilateral ground-glass opacity, multiple lobular, or subsegmental areas of consolidation; (3) being at high risk of 2019-nCoV infection because the patient's family members or caregivers have been diagnosed with 2019-nCoV infection, had close contact with someone with probable or confirmed 2019-nCoV, had close contact with someone with pneumonia of unknown cause, are living in or travelling to epidemic areas, or have been in animal markets or close contact with wild animals, within 14 days before the onset of illness. Those who meet the criteria of probable infection and have positive virus detection tests are confirmed to be infected with 2019-nCoV. All probable or laboratory-confirmed neonates with 2019-nCoV should be admitted to NICUs. Standard and additional precautions should be implemented immediately (panel). General management comprises homoeostasis maintenance, close follow-up of blood work and chest radiography, and initialisation of respiratory support if necessary. The efficacy of antiviral drugs against 2019-nCoV is not certain.7Totura AL Bavari S Broad-spectrum coronavirus antiviral drug discovery.Expert Opin Drug Discov. 2019; 14: 397-412Crossref PubMed Scopus (144) Google Scholar Antimicrobial drugs are only prescribed to patients with probable or confirmed bacterial infection; empirical use or overuse should be avoided. For neonates with acute respiratory distress syndrome manifested by complete opacification of lungs, high-dose pulmonary surfactant replacement, nitric oxide inhalation, and high-frequency oscillatory ventilation might be effective. Intravenous glucocorticoids or immunoglobulin could be tried in some difficult cases. Neonates with intracranial infection and convulsion should be handled according to corresponding guidelines. In critically ill neonates, continuous renal replacement and extracorporeal membrane oxygenation could be implemented if necessary. Those who have no fever for at least 3 days and improved respiratory symptoms; resolution of previously abnormal chest radiography findings; and a series of two nasopharyngeal and nasal swabs negative for 2019-nCoV at least 48 h apart could be discharged home.PanelStrategies to be implemented during screening of neonates for 2019-nCoV infection•Standard precautions include signage at the entrance, strict hand and respiratory hygiene, daily cleaning and disinfection of the environment, and provision of gloves, mask, and goggles for all medical staff•Additional enhanced contact precautions and respiratory droplet precautions include patients' own dedicated equipment, limited parents' visits, gown and glove change after procedures, and opening window regularly to change air•Avoid breastfeeding from mothers with probable or laboratory-confirmed 2019-nCoV infection until the recovery of confirmed mothers or rejection of probable infection•Medical waste generated during medical service should be collected into a double-layer infectious waste bag, which should be treated with chlorine-containing preparation for at least 10 min, then disposed of in the same way as infectious medical waste•Terminal disinfection of the patient's room is preferentially done using hydrogen peroxide atomisation or a chlorine-containing preparation spray •Standard precautions include signage at the entrance, strict hand and respiratory hygiene, daily cleaning and disinfection of the environment, and provision of gloves, mask, and goggles for all medical staff•Additional enhanced contact precautions and respiratory droplet precautions include patients' own dedicated equipment, limited parents' visits, gown and glove change after procedures, and opening window regularly to change air•Avoid breastfeeding from mothers with probable or laboratory-confirmed 2019-nCoV infection until the recovery of confirmed mothers or rejection of probable infection•Medical waste generated during medical service should be collected into a double-layer infectious waste bag, which should be treated with chlorine-containing preparation for at least 10 min, then disposed of in the same way as infectious medical waste•Terminal disinfection of the patient's room is preferentially done using hydrogen peroxide atomisation or a chlorine-containing preparation spray All neonates newly admitted to the NICU need to be screened for high risk of 2019-nCoV infection (panel). Neonates at high risk, as assessed by family history, should be isolated in a single room for at least 14 days. If a neonate develops manifestations similar to 2019-nCoV infection during the isolation period or is highly suspected of 2019-nCoV infection on admission, the patient should be immediately referred to a designated hospital or a designated unit for 2019-nCoV infection. The patient's room cannot be used by other patients before being adequately disinfected. If this patient shared a room with other neonates before being identified, all wardmates should be isolated. Isolation must last at least 14 days, unless 2019-nCoV infection is ruled out. In NICUs, a virus outbreak will bring psychological stress to the patient's parents and other family members; therefore, social workers and psychologists should be involved. Medical service providers will also be under tremendous psychological pressure due to overwork, shortage of medical resources, patients' poor outcomes, or other detrimental experiences. Medical staff should be provided with adequate psychological support, as their physical and mental health is crucial in the context of a virus outbreak. Most of our recommendations are based on lessons learned from existing and previous experiences with coronavirus outbreaks in adults and children. The contingency plan will be continuously modified on the basis of accumulated clinical evidence and experience. Medical service providers should also continually update their knowledge and skills on prevention and control of the 2019-nCoV outbreak. We declare no competing interests. JW and HQ contributed equally. Managing neonates with respiratory failure due to SARS-CoV-2In their Comment in The Lancet Child & Adolescent Health, Jianhui Wang and colleagues1 suggested a plan to handle neonates with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and outbreaks in neonatal intensive care units (NICUs). This is a timely reflection, given the public health problem represented by this infection and the need to anticipate any critical care issue, irrespective of patients' ages. Full-Text PDF Managing neonates with respiratory failure due to SARS-CoV-2 – Authors' replyWe thank Daniele De Luca for his reflections on our Comment.1 We agree that testing all admitted neonates for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not necessary. We recommended screening all newly admitted infants at high risk of coronavirus disease 2019 (COVID-19) on the basis of their family history. Only high-risk patients should receive a nucleic acid test for SARS-CoV-2. However, all high-risk neonates should be isolated in a single room, preferably in a neonatal intensive care unit (NICU). Full-Text PDF

Neonatal Management During the Coronavirus Disease (COVID-19) Outbreak: the Chinese Experience.

Impact of the COVID-19 pandemic on infectious disease hospitalizations of neonates at a tertiary academic hospital: a cross-sectional study

[Possibility of Mother-to-child Vertical Transmission of Coronavirus Infection from the Perspectives of Severe Acute Respiratory Syndrome, Middle East Respiratory Syndrome, and Coronavirus Disease 2019].

Chinese Expert Consensus on the Perinatal and Neonatal Management for the Prevention and Control of the 2019 Novel Coronavirus Infection (first Edition)

Error in the Abstract and Results Section

A Contingency Plan for the Management of the 2019 Novel Coronavirus Outbreak in Neonatal Intensive Care Units

Birth Outcomes of Pregnant Women Infected with COVID-19 in Highland Areas of China from 2020 to 2022: A Retrospective Analysis

Is Termination of Early Pregnancy Indicated in Women with COVID-19?

Clinical Characteristics and Risk Assessment of Newborns Born to Mothers with COVID-19.

Retrospective Analysis of Clinical Characteristics and Neonatal Outcomes of Pregnant Women with SARS-COV-2 Infection

Clinical Analysis of Neonates Born to Mothers with or without COVID-19: A Retrospective Analysis of 48 Cases from Two Neonatal Intensive Care Units in Hubei Province

Severe Acute Respiratory Syndrome Coronavirus 2(Sars-Cov-2) Infection During Late Pregnancy: a Report of 18 Patients from Wuhan, China

Challenges and Improvement in Management of Neonates Born to Mothers with COVID-19 in China

Maternal and neonatal outcomes in pregnant women with COVID-19: a systemic review

Clinical characteristics and outcomes of neonatal SARS-CoV-2 infection after the release of the epidemic situation of COVID-19

Neonatal Outcome in 29 Pregnant Women with COVID-19: A Retrospective Study in Wuhan, China

Clinical Analysis of 10 Neonates Born to Mothers with 2019-Ncov Pneumonia

Characteristics and Risks of COVID-19 in Pregnant Women & Neonates: A Retrospective, Age-matched Comparison Study—Wuhan Experience in the Management of Peripartum Health

Clinical features of neonates born to mothers with coronavirus disease-2019: A systematic review of 105 neonates

[Management and short-term outcomes of neonates born to mothers infected with SARS-CoV-2 Omicron variant].

Novel coronavirus infection in newborn babies aged <28 days in China.